Skip to main content
SpringerLink
Log in

Letter to the Editor regarding the article “The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions”

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018) The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions. Heart Fail Rev 23(3):303–323

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Hempel P, Karczewski P, Kohnert KD, Raabe J, Lemke B, Kunze R, Bimmler M (2009) Sera from patients with type 2 diabetes contain agonistic antibodies against G protein-couplet receptors. Scand J Immunol 70:159–160

    Article  PubMed  CAS  Google Scholar 

  3. Zhao LS, Liao YH, Xiang GD, Wang M, Yue L, Zhou ZH, Sun HL (2010) Positive rate of autoantibodies against adrenergic receptors beta1 and angiotensin II type 1 receptors in the type 2 diabetes mellitus with or without hypertension. Zhonghua Xin Xue Guan Bing Za Zhi 38:139–140

    PubMed  Google Scholar 

  4. Dandel M, Englert A, Wallukat G, Riese A, Knosalla C, Stein J, Hetzer R (2015) Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus. Atheroscler Suppl 18:124–133

    Article  PubMed  Google Scholar 

  5. Zhao L, Xu C, Xu J (2014) Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation. Cardiology 129(3):191–196

    Article  PubMed  CAS  Google Scholar 

  6. Dandel M, Wallukat G, Englert A, Riese A, Knosalla C, Stein J, Hetzer R (2012) Long-term benefits of immunoadsorption in beta-1 adrenoreceptor autoantibody positive transplant candidates with dilated cardiomyopathy. Eur J Heart Fail 14(12):1374–1388

    Article  PubMed  CAS  Google Scholar 

  7. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH (2013) Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 28:145–284

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. German Centre for Heart and Circulatory Research (DZHK), Partner site Berlin, Berlin, Germany

    Michael Dandel

  2. Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353, Berlin, Germany

    Michael Dandel & Roland Hetzer

  3. Berlin Cures GmbH, Berlin, Germany

    Gerd Wallukat

  4. Cardio Centrum Berlin, Berlin, Germany

    Roland Hetzer

Authors
  1. Michael Dandel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerd Wallukat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roland Hetzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Dandel.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dandel, M., Wallukat, G. & Hetzer, R. Letter to the Editor regarding the article “The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions”. Heart Fail Rev 23, 817–818 (2018). https://doi.org/10.1007/s10741-018-9725-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-018-9725-9

Search

Navigation